In vivo experiments have shown that XIAP knockdown promoted HFD-induced oxidative stress injury and NLRP3 signaling-related lipid deposition in the liver of mice, further stimulating the development of NAFLD. Here, XIAP is linked to metabolic dysfunction-associated steatotic liver disease.